The estimated national burden of asthma in India is at 17.23 million with an overall prevalence of 2.05% and out of this, approximately 30 lakh patients can be classified under “inadequately controlled”
Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, AbbVie, Abbott Laboratories, and G.D. Searle and Co
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
MindRank expects to initiate a Phase I safety study in the first quarter of 2023.
Fulvestrant Injection, 250 mg/5 mL, has an estimated market size of US $71 million for twelve months ending Sep 2022 according to IQVIA
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Indira IVF integrates diagnostics services with a special focus on women & child care to increase accessibility for patients
Global pharmaceutical company having a surgical business concept incepted in Dubai
Subscribe To Our Newsletter & Stay Updated
